Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.
Longitudinal dynamics of cardiometabolic parameters in a MASH population stratified by baseline glycemia and treated with semaglutide: post hoc insights from the ESSENCE trial part 1
Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.